Ying X - Search Results

1

Effectiveness of combined (131)I-chTNT and radiofrequency ablation therapy in treating advanced hepatocellular carcinoma.

Tu J, Ji J, Wu F, Wang Y, Zhang D, Zhao Z, Ying X. Tu J, et al. Among authors: ying x. Cell Biochem Biophys. 2015 Mar;71(2):777-84. doi: 10.1007/s12013-014-0262-4. Cell Biochem Biophys. 2015. PMID: 25293788

2

[Efficacies of ¹³¹I-chTNT plus radiofrequency ablation for the treatment of advanced hepatocellular carcinoma].

Tu J, Ji J, Wu F, Zhang D, Ying X, Zhao Z. Tu J, et al. Among authors: ying x. Zhonghua Yi Xue Za Zhi. 2014 Dec 9;94(45):3586-8. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25622840 Chinese.

3

Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma.

Tu JF, Pan HY, Ying XH, Lou J, Ji JS, Zou H. Tu JF, et al. Medicine (Baltimore). 2016 Mar;95(13):e3220. doi: 10.1097/MD.0000000000003220. Medicine (Baltimore). 2016. PMID: 27043690 Free PMC article.

4

[Efficacy analysis of radiofrequency ablation combined with 125I seed for multiple nodular hepatocellular carcinoma].

Wu FZ, Ji JS, Ying XH, Tu JF, Zhao ZW, Wu XL, Yang HY, Zhang DK, Chen L, Song JJ. Wu FZ, et al. Among authors: ying xh. Zhonghua Yi Xue Za Zhi. 2016 Mar 8;96(9):693-6. doi: 10.3760/cma.j.issn.0376-2491.2016.09.006. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27055506 Chinese.

5

Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.

Song J, Zhao Z, Fan X, Chen M, Cheng X, Zhang D, Wu F, Ying X, Ji J. Song J, et al. Among authors: ying x. Oncotarget. 2016 Oct 25;7(43):70504-70515. doi: 10.18632/oncotarget.12041. Oncotarget. 2016. PMID: 27655700 Free PMC article.

6

Regulatory T cells, especially ICOS⁺ FOXP3⁺ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival.

Tu JF, Ding YH, Ying XH, Wu FZ, Zhou XM, Zhang DK, Zou H, Ji JS. Tu JF, et al. Sci Rep. 2016 Oct 11;6:35056. doi: 10.1038/srep35056. Sci Rep. 2016. PMID: 27725696 Free PMC article.

7

The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.

Tu J, Jia Z, Ying X, Zhang D, Li S, Tian F, Jiang G. Tu J, et al. Among authors: ying x. Medicine (Baltimore). 2016 Dec;95(49):e5606. doi: 10.1097/MD.0000000000005606. Medicine (Baltimore). 2016. PMID: 27930585 Free PMC article.

8

ShRNA knock-down of CXCR7 inhibits tumour invasion and metastasis in hepatocellular carcinoma after transcatheter arterial chemoembolization.

Zhao ZW, Fan XX, Song JJ, Xu M, Chen MJ, Tu JF, Wu FZ, Zhang DK, Liu L, Chen L, Ying XH, Ji JS. Zhao ZW, et al. J Cell Mol Med. 2017 Sep;21(9):1989-1999. doi: 10.1111/jcmm.13119. Epub 2017 Apr 21. J Cell Mol Med. 2017. PMID: 28429395 Free PMC article.

9

Evaluation of the blood supply and efficacy of transcatheter arterial chemoembolization for patients with liver metastasis using ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography.

Wang ZF, Fan XX, Xu M, Chen MJ, Zhao ZW, Zhou JD, Tu JF, Song JJ, Hu XH, Lu CY, Wu FZ, Zhang DK, Chen L, Liu L, Ying XH, Xu XF, Ji JS. Wang ZF, et al. Tumour Biol. 2017 May;39(5):1010428317701656. doi: 10.1177/1010428317701656. Tumour Biol. 2017. PMID: 28475013 Free article.

10

Iodine-125 Brachytherapy Prophylaxis after Radiofrequency Ablation Cannot Benefit Patients in High Risk of Locoregional Hepatocellular Carcinoma Recurrence.

Tu JF, Ding YH, Chen L, Ying XH, Zhang DK, Wu FZ, Zhao ZW, Ji JS, Zhang WG, Zou H. Tu JF, et al. Sci Rep. 2017 Jun 16;7(1):3689. doi: 10.1038/s41598-017-03831-5. Sci Rep. 2017. PMID: 28623296 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,354 results

Search Page

Filters